End-of-day quote
Other stock markets
|
||
- GBX | - |
05-14 | RELX : UBS remains its Buy rating | ZD |
05-14 | UBS Raises Relx PT, Keeps Buy Rating | MT |
Sales 2024 * | 9.75B 12.39B 16.86B | Sales 2025 * | 10.33B 13.12B 17.86B | Capitalization | 64.58B 82.02B 112B |
---|---|---|---|---|---|
Net income 2024 * | 2.04B 2.59B 3.52B | Net income 2025 * | 2.23B 2.83B 3.85B | EV / Sales 2024 * | 7.27 x |
Net Debt 2024 * | 6.31B 8.01B 10.9B | Net Debt 2025 * | 6.17B 7.84B 10.67B | EV / Sales 2025 * | 6.85 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
29.1
x | Employees | - |
Yield 2024 * |
1.82% | Yield 2025 * |
1.97% | Free-Float | 98.25% |
Latest transcript on Reed Elsevier plc
Managers | Title | Age | Since |
---|---|---|---|
Erik Engstrom
CEO | Chief Executive Officer | 60 | 03-12-31 |
Nick Luff
DFI | Director of Finance/CFO | 57 | 14-04-23 |
Vijay Raghavan
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charlotte Hogg
BRD | Director/Board Member | 53 | 19-12-15 |
Andrew Sukawaty
BRD | Director/Board Member | 69 | 19-04-24 |
Nick Luff
DFI | Director of Finance/CFO | 57 | 14-04-23 |
1st Jan change | Capi. | |
---|---|---|
-13.48% | 191B | |
+1.53% | 167B | |
+3.37% | 155B | |
+8.31% | 103B | |
+35.49% | 83.67B | |
-6.43% | 71.79B | |
-18.66% | 54.05B | |
-8.68% | 43.34B | |
+9.88% | 38.62B |